Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,000 | 40,000 | 37,900 | 61,100 | 38,300 |
| Receivables | 113,200 | 110,100 | 113,500 | 118,500 | 115,600 |
| Inventories | 120,500 | 119,500 | 114,500 | 120,500 | 125,300 |
| Income taxes - deferred | 8,000 | 8,000 | 9,400 | 11,900 | 28,900 |
| Other current assets | 0 | 0 | 0 | 6,400 | 0 |
| TOTAL | $326,200 | $333,300 | $326,700 | $360,200 | $368,300 |
| Non-Current Assets | |||||
| PPE Net | 189,500 | 193,500 | 203,700 | 209,900 | 205,900 |
| Investments And Advances | 21,900 | 26,700 | 37,600 | 35,400 | 28,400 |
| Intangibles | 487,800 | 488,600 | 491,200 | 419,200 | 418,900 |
| Other Non-Current Assets | 46,500 | 47,500 | 44,600 | 76,700 | 49,300 |
| TOTAL | $745,700 | $756,300 | $777,100 | $741,200 | $702,500 |
| Total Assets | $1,071,900 | $1,089,600 | $1,103,800 | $1,101,400 | $1,070,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 170,300 | 156,000 | 156,400 | 184,100 | 172,000 |
| TOTAL | $170,300 | $156,000 | $156,400 | $184,100 | $172,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 269,200 | 312,800 | 334,500 | 255,800 | 293,100 |
| Other Non-Current Liabilities | 33,100 | 34,600 | 42,700 | 26,400 | 27,000 |
| TOTAL | $302,300 | $347,400 | $377,200 | $282,200 | $320,100 |
| Total Liabilities | $472,600 | $503,400 | $533,600 | $466,300 | $492,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 713,332 | 716,426 | 713,331 | 715,946 | 711,128 |
| Common Shares | 63,800 | 63,700 | 63,100 | 62,600 | 62,100 |
| Retained earnings | 198,200 | 185,800 | 160,300 | 222,400 | 203,500 |
| Other shareholders' equity | -34,200 | -37,600 | -28,200 | -32,100 | -46,100 |
| TOTAL | $599,300 | $586,200 | $570,200 | $635,100 | $578,700 |
| Total Liabilities And Equity | $1,071,900 | $1,089,600 | $1,103,800 | $1,101,400 | $1,070,800 |